Whitehawk Therapeutics Inc
WHWK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $26 | $24 | $15 | $1 |
| % Growth | 6.7% | 60.1% | 1,258.6% | – |
| Cost of Goods Sold | $54 | $52 | $34 | $20 |
| Gross Profit | -$28 | -$27 | -$19 | -$19 |
| % Margin | -108% | -112.4% | -123.4% | -1,656.3% |
| R&D Expenses | $51 | $49 | $33 | $20 |
| G&A Expenses | $0 | $0 | $0 | $19 |
| SG&A Expenses | $37 | $45 | $40 | $19 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$48 | -$49 | -$29 | $54 |
| Operating Expenses | $39 | $45 | $44 | $93 |
| Operating Income | -$67 | -$72 | -$63 | -$111 |
| % Margin | -259.6% | -295.4% | -411.9% | -9,930.1% |
| Other Income/Exp. Net | $4 | $6 | $2 | $1 |
| Pre-Tax Income | -$64 | -$66 | -$61 | -$110 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$64 | -$66 | -$61 | -$110 |
| % Margin | -245.1% | -270% | -397.7% | -9,829.5% |
| EPS | -2.36 | -2.44 | -2.69 | -12.41 |
| % Growth | 3.3% | 9.3% | 78.3% | – |
| EPS Diluted | -2.36 | -2.44 | -2.69 | -12.41 |
| Weighted Avg Shares Out | 27 | 27 | 23 | 9 |
| Weighted Avg Shares Out Dil | 27 | 27 | 23 | 9 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $6 | $2 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$65 | -$72 | -$59 | -$37 |
| % Margin | -248.7% | -294.7% | -386.4% | -3,299.6% |